HyLeukin-7

NeoImmuneTech and Roche Collaborate in Clinical Trial of HyLeukin-7 in Combination with a PD-L1 Checkpoint Inhibitor in Advanced High-Risk Skin Cancers
Tue, 05/1/18 - 09:16 pm
NeoImmune Tech
Genexine
Roche
HyLeukin-7
checkpoint inhibitors
melanoma